Search Within

Neeta Pandit-Taskar

Formats
  1. Meeting Abstract (156)
  2. Journal Article (142)
  3. Review (20)
  4. Book Section (17)
  5. Guidelines (5)
  6. Editorial (2)
Groups
  1. Molecular Imaging and Therapy Service (342)
  2. Radiology, Department of (342)
  3. GSK Faculty (145)
  4. Medical Physics (126)
  5. Department of Medicine (120)
  6. Molecular Pharmacology and Chemistry Program Faculty (103)

More Groups

People
  1. Steven Larson (99)
  2. Jorge Carrasquillo (77)
  3. Pat Zanzonico (57)
  4. Jason Lewis (52)
  5. Serge Lyashchenko (52)
  6. Kim Kramer (51)

More People

Years
  1. 2025 (5)
  2. 2024 (21)
  3. 2023 (31)
  4. 2022 (33)
  5. 2021 (21)
  6. 2020 (12)

More Years

Publications
  1. Journal of Nuclear Medicine (66)
  2. Journal of Clinical Oncology (48)
  3. European Journal of Nuclear Medicine and Molecular Imaging (21)
  4. Pediatric Blood and Cancer (21)
  5. Neuro-Oncology (20)
  6. Blood (13)

More Publications

Publishers
  1. Society of Nuclear Medicine (66)
  2. Springer (49)
  3. American Society of Clinical Oncology (48)
  4. Elsevier Inc. (38)
  5. Oxford University Press (23)
  6. Wiley Periodicals, Inc (21)

More Publishers

Results (342)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Post-treatment 18F-FDG PET/CT surveillance for detection of recurrence in stage III Merkel cell carcinoma
    Meeting Abstract

    Mahajan, S.; Barker, C.; Pandit-Taskar, N.
    Journal of Nuclear Medicine (2019)

    Fulltext@MSK | Save
  • Optimizing dosimetry imaging in high-dose radioimmunotherapy using the novel, anti-CD45 re-induction and targeted conditioning agent iodine (131)I apamistamab [Iomab-B] in patients 55 years or older with active, relapsed or refractory acute myeloid leukemia (SIERRA phase III trial)
    Meeting Abstract

    Pandit-Taskar, N.; Passalaqua, S.; Wiseman, G.; Avril, N.; Yap, W.; Chen, M. K.; Wagner, R.; Natwa, M.; Chasen, B.; Lamonica, D.; more...
    Journal of Nuclear Medicine (2019)

    Fulltext@MSK | Save
  • Personalized dosimetry using (131)I-anti-CD45-apamistamab (Iomab-B) prior to high-dose myeloablative radioimmunotherapy for hematopoietic stem cell transplant (HCT) in active, relapsed, or refractory acute myelogenous leukemia: Novel re-induction and targeted conditioning feasibility and engraftment results from the SIERRA trial
    Meeting Abstract

    Griffeth, L.; Passalaqua, S.; Wiseman, G.; Avril, N.; Yap, W.; Chen, M. K.; Wagner, R.; Natwa, M.; Chasen, B.; Lamonica, D.; more...
    Journal of Nuclear Medicine (2019)

    Fulltext@MSK | Save
  • (89)Zr-immuno-PET: Towards a non-invasive clinical tool to measure target engagement of therapeutic antibodies in-vivo
    Meeting Abstract

    Jauw, Y.; O'Donoghue, J.; Zijlstra, J.; Hoekstra, O.; Menke-van der Houven van Oordt, C.; Morschhauser, F.; Carrasquillo, J.; Zweegman, S.; Pandit-Taskar, N.; Lammertsma, A.; more...
    Journal of Nuclear Medicine (2019)

    Fulltext@MSK | Save
  • Pharmacokinetics and biodistribution of a [(86)Zr]Zr-DFO-MSTP2109A anti-STEAP1 antibody in metastatic castration-resistant prostate cancer patients
    Journal Article

    O'Donoghue, J. A.; Danila, D. C.; Pandit-Taskar, N.; Beylergil, V.; Cheal, S. M.; Fleming, S. E.; Fox, J. J.; Ruan, S.; Zanzonico, P. B.; Ragupathi, G.; more...
    Molecular Pharmaceutics (2019)

    Fulltext@MSK | Save
  • Clinical value of (18)F-FDG-PET/CT in staging cutaneous squamous cell carcinoma
    Journal Article

    Mahajan, S.; Barker, C. A.; Singh, B.; Pandit-Taskar, N.
    Nuclear Medicine Communications (2019)

    Fulltext@MSK | Save
  • Targeted radioimmunotherapy for embryonal tumor with multilayered rosettes
    Journal Article

    Bailey, K.; Pandit-Taskar, N.; Humm, J. L.; Zanzonico, P.; Gilheeney, S.; Cheung, N. K. V.; Kramer, K.
    Journal of Neuro-Oncology (2019)

    Fulltext@MSK | Save
  • Radium-223 in combination with docetaxel in patients with castration-resistant prostate cancer and bone metastases: A phase 1 dose escalation/randomised phase 2a trial
    Journal Article

    Morris, M. J.; Loriot, Y.; Sweeney, C. J.; Fizazi, K.; Ryan, C. J.; Shevrin, D. H.; Antonarakis, E. S.; Pandit-Taskar, N.; Deandreis, D.; Jacene, H. A.; more...
    European Journal of Cancer (2019)

    Fulltext@MSK | Save
  • Biodistribution and radiation dose estimates for (68)Ga-DOTA-JR11 in patients with metastatic neuroendocrine tumors
    Journal Article

    Krebs, S.; Pandit-Taskar, N.; Reidy, D.; Beattie, B. J.; Lyashchenko, S. K.; Lewis, J. S.; Bodei, L.; Weber, W. A.; O'Donoghue, J. A.
    European Journal of Nuclear Medicine and Molecular Imaging (2019)

    Fulltext@MSK | Save
  • EGFR and MET amplifications determine response to HER2 inhibition in ERBB2-amplified esophagogastric cancer
    Journal Article

    Sanchez-Vega, F.; Hechtman, J. F.; Castel, P.; Ku, G. Y.; Tuvy, Y.; Won, H.; Fong, C. J.; Bouvier, N.; Nanjangud, G. J.; Soong, J.; more...
    Cancer Discovery (2019)

    Fulltext@MSK | Save